Drug intelligence / Profile preview

magnesium citrate

Development stage: Phase 3
Lead developer: Bio Concepts
Modality: Small Molecules
Administration: Oral

Overview

Citramag is a marketed osmotic laxative primarily used as a bowel evacuant to prepare patients for diagnostic or surgical procedures, such as colonoscopies or barium enemas. Developed and manufactured by Cambridge Healthcare Supplies, the product is supplied as a powder containing magnesium carbonate and citric acid, which react in water to form magnesium citrate. Its mechanism of action involves drawing water into the intestinal lumen through osmosis, thereby increasing intraluminal pressure and stimulating bowel evacuation. It is intended for short-term bowel cleansing rather than the treatment of chronic constipation and is available in multiple countries worldwide.

Brand names: Citramag
Other names: Magnesium citrate

Beyond the preview

Go deeper on magnesium citrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium citrate.

Explore the full profile